✦ LIBER ✦

P.6.029 Efficacy in a 5 month trial of methylphenidate in adults with attention-deficit/hyperactivity disorder

✍ Scribed by Spencer, T.; Biederman, J.; Mick, E.; Faraone, S.V.

Book ID: 123057613
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 119 KB
Volume: 14
Category: Article
ISSN: 0924-977X
DOI: 10.1016/S0924-977X(04)80533-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theres 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A controlled trial of methylphenidate in

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

✍ Pieter J. Carpentier; Cor A. J. De Jong; Boukje A. G. Dijkstra; Cor A. G. Verbru 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Methylphenidate-induced improvements of

Methylphenidate-induced improvements of various measures of attention in adults with Attention Deficit Hyperactivity Disorder

✍ O. Tucha; L. Mecklinger; R. Laufkötter; H. E. Klein; S. Walitza; K. W. Lange 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 134 KB

P.7.c.003 12-month safety and efficacy o

P.7.c.003 12-month safety and efficacy of methylphenidate transdermal system in attention-deficit/hyperactivity disorder

✍ J.M. Turnbow; R.L. Findling; F.A. López; J.C. Burnside; O.G. Bukstein 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy of reboxetine in adults with at

Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial

✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

Treatment discontinuation with methylphe

Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials

✍ Xavier Castells,Ruth Cunill,Dolors Capell 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 337 KB